AI heart disease prediction tools show promise but are not ready for clinical use: review
A systematic review by researchers from India and the UK suggests that while AI shows promise for predicting cardiovascular disease, current models are not yet ready for routine clinical use. The study emphasizes the need for rigorous independent validation of these tools.
Artificial intelligence (AI) could help India identify people at risk of cardiovascular disease (CVD) earlier and enable more personalised prevention, but the technology is not yet ready to guide routine clinical decisions, according to a recent systematic review by researchers from the Indian Institute of Science (IISc), M.S. Ramaiah University of Applied Sciences, and the London School of Hygiene and Tropical Medicine.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in